"iDoctor – Medical Blog"

Publication year: 2009<br><b>Source:</b> The American Journal of Cardiology, Volume 104, Issue 8, 15 October 2009, Pages 1063-1068<br>Bernardo, Cortese , Andrea, Picchi , Andrea, Micheli , Alberto Genovesi, Ebert , Francesca, Parri , …<br><br>Modern antithrombotic strategies for patients undergoing percutaneous coronary interventions (PCIs) must take into account the risk of ischemic and hemorrhagic complications. Bivalirudin decreases the risk of hemorrhagic complications after PCI; however, concerns have been raised about its efficacy in preventing ischemic complications. We evaluated the effectiveness of a prolonged intra- and postprocedural bivalirudin infusion versus a standard regimen in preventing

This entry was posted on Saturday, October 3rd, 2009 at 3:14 am and is filed under Health news. You can follow any responses to this entry through the RSS 2.0 feed. You can skip to the end and leave a response. Pinging is currently not allowed.